Issue
Number 620
September 11, 2006
CONTENTS OF THIS ISSUE
- New: CDC releases interim VIS for human papillomavirus
vaccine
- Postexposure prophylaxis urged for those exposed to
rabid horse at Tennessee Walking Horse 2006 National Celebration
- More than 100 million doses of influenza vaccine will be
produced for the U.S. market for 2006-07
- Influenza vaccine VISs available in Spanish; other
immunization educational pieces now in Arabic, Thai, and Japanese
- New: Current Issues in Immunization net conference to
focus on avian influenza
- New: Federal government launches Pandemic Influenza
website in Spanish-language format
- Reminder that perinatal hepatitis B virus (HBV) is a
nationally notifiable condition
- September 7 issue of Hep Express electronic newsletter
available online
- CDC reports on 2006 measles outbreak in Fiji
----------------------------------------------------------
Back to Top
---------------------------------------------------------------
ABBREVIATIONS: AAFP, American Academy of Family Physicians; AAP, American
Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices;
CDC, Centers for Disease Control and Prevention; FDA, Food and Drug
Administration; IAC, Immunization Action Coalition; MMWR, Morbidity and
Mortality Weekly Report; NIP, National Immunization Program; VIS, Vaccine
Information Statement; VPD, vaccine-preventable disease; WHO, World Health
Organization.
---------------------------------------------------------------
(1 of 9)
September 11, 2006
NEW: CDC RELEASES INTERIM VIS FOR HUMAN PAPILLOMAVIRUS VACCINE
On September 5, CDC released an interim VIS for human papillomavirus (HPV)
vaccine. The final VIS will be developed after ACIP recommendations are
published in MMWR and the vaccine
is covered by the Vaccine Injury Compensation Program.
To obtain a ready-to-print (PDF) version of the interim VIS from the CDC
website, go to:
http://www.cdc.gov/nip/publications/VIS/vis-hpv.pdf
To obtain it from the IAC website, go to:
http://www.immunize.org/vis/hpv.pdf
For information about the use of VISs, and for VISs in more than 30
languages, visit IAC's VIS web section at
http://www.immunize.org/vis
---------------------------------------------------------------
Back to Top
(2 of 9)
September 11, 2006
POSTEXPOSURE PROPHYLAXIS URGED FOR THOSE EXPOSED TO RABID HORSE AT TENNESSEE
WALKING HORSE 2006 NATIONAL CELEBRATION
On September 9, CDC issued a Health Advisory reporting that a horse stabled
on the grounds of the Tennessee Walking Horse 2006 National Celebration
tested positive for rabies. Approximately 150,000 people attended the event.
The Health Advisory is reprinted below in its entirety.
PLEASE NOTE: The CDC'S Health Alert Network (HAN) website has been
relocated. If you maintain or contribute to a website that links to the CDC
HAN website you should update the link. The new website location is
http://www2a.cdc.gov/HAN
************************
This is an official CDC Health Advisory
Distributed via Health Alert Network
Saturday, September 9, 2006, 20:44 EDT (08:44 PM EDT)
HORSE STABLED AT TENNESSEE WALKING HORSE 2006 NATIONAL CELEBRATION TESTED
POSITIVE FOR RABIES
The Tennessee Department of Health (TDH) with the assistance of the Centers
for Disease Control and Prevention (CDC) are notifying the approximately
150,000 persons who attended the Tennessee Walking Horse National
Celebration in Shelbyville of a confirmed case of rabies in a horse stabled
on the grounds during the event. If persons were bitten or came in contact
with saliva from this horse (described below) from August 23-31, 2006, while
attending the Celebration, they may have been exposed to rabies and are
invited to contact TDH for an assessment.
Rabies is a viral infection that nearly always results in fatal
encephalitis. Humans may be exposed to rabies primarily through the bite of
a rabid animal or when the virus is introduced into fresh open cuts in the
skin or onto mucous membranes such as the eyes, mouth, or nose from the
saliva of a rabid animal. Attending an event where a rabid animal was
present, petting a rabid animal, or contact with the blood, urine, or feces
of a rabid animal does not constitute a risk for transmission. If a person
is exposed to rabies, a series of shots (postexposure prophylaxis) is highly
effective in preventing the disease.
Among the approximate 150,000 persons who attended the Tennessee Walking
Horse National Celebration, the number and origin (U.S. states or other
countries) of persons who may have been exposed to this horse are unknown.
TDH is currently working with event organizers and managers to identify
additional mechanisms to contact participants and visitors.
The horse that developed rabies was from Waynesville, Missouri. It was a
3-year-old gelding (neutered male horse), buckskin (cream to tan) in color
with a black mane and tail. "Buck" or "Bucky" was described as "small," 14
hands or 56 inches tall at the withers (i.e., the highest area of the
shoulders at the base of the neck). He was stabled on the north side of Barn
50 in stall #12, the third from the west end. A bright blue curtain labeled
"4J Land and Cattle Company" covered the outside porch of the barn. The
potential for contact by the public was very limited when the horse was in
its stall but there may have been opportunity for public contact when the
horse was taken for rides on the Celebration grounds. The horse was first
noted to be ill on August 28. Over the next few days, the horse developed
severe neurological signs and, as a result, was euthanized. Persons directly
involved in the care of the horse are being assessed for possible rabies
exposure and the need for rabies postexposure treatment.
If the individual
-
was bitten by a horse;
-
had contamination of a fresh open wound with saliva from a horse; or
-
had saliva from a horse come in contact with eyes, nose, mouth or other
mucous membranes.
Personnel are available to answer additional questions at the Tennessee
Department of Health Public Information Line (866) 355-6129.
************************
To access the Health Advisory, go to:
http://www2a.cdc.gov/HAN/ArchiveSys/ViewMsgV.asp?AlertNum=00248
---------------------------------------------------------------
Back to Top
(3 of 9)
September 11, 2006
MORE THAN 100 MILLION DOSES OF INFLUENZA VACCINE WILL BE PRODUCED FOR THE
U.S. MARKET FOR 2006-07
On September 6, CDC issued a press release titled "More than 100 million
doses of influenza vaccine expected to be available this year." A portion of
the press release is reprinted below.
*************************
Influenza vaccine manufacturers report that they expect to produce more than
100 million doses of influenza vaccine for the U.S. market this year. This
is at least 17 million more doses of influenza vaccine than has ever been
distributed in the past (previous high was 83.1 million doses in 2003) and
about 19 million more doses than were distributed last year (81.2 million).
According to the information from manufacturers, about 75 million doses will
be distributed by the end of October; that would be about 15 million more
doses than were distributed by the end of October 2005.
*************************
To access the complete press release, go to:
http://www.cdc.gov/od/oc/media/pressrel/r060906b.htm
---------------------------------------------------------------
Back to Top
(4 of 9)
September 11, 2006
INFLUENZA VACCINE VISs AVAILABLE IN SPANISH; OTHER IMMUNIZATION
EDUCATIONAL PIECES NOW IN ARABIC, THAI, AND JAPANESE
IAC recently posted the following resources to its website: (1)
Spanish-language VIS for injectable trivalent inactivated influenza
vaccine (TIV; dated 6/30/06), (2) Spanish-language VIS for intranasal live
attenuated influenza vaccine (LAIV; dated 6/30/06),(3) Arabic-language VIS
for MMR vaccine (dated 1/15/03), (4) Thai-language interim VIS for
meningococcal vaccine (dated 10/7/05), and (5) Japanese-language version
of the IAC patient-education piece "After the shots. . . what to do if
your child has discomfort" (dated 9/04).
IAC gratefully acknowledges the California Department of Health Services
(Davis, CA) for the Spanish and Arabic translations, Asian Pacific Health
Care Venture (Los Angeles) for the Thai translation, and Arnett Clinic
(Lafayette/West Lafayette, IN) for the Japanese translation.
VACCINE INFORMATION STATEMENTS
To obtain a ready-to-print (PDF) version of the VIS for TIV vaccine in
Spanish, go to:
http://www.immunize.org/vis/spflu06.pdf
To obtain it in English, go to:
http://www.immunize.org/vis/2flu.pdf
To obtain a ready-to-print (PDF) version of the VIS for LAIV vaccine in
Spanish, go to:
http://www.immunize.org/vis/spliveflu06.pdf
To obtain it in English, go to:
http://www.immunize.org/vis/liveflu.pdf
To obtain a ready-to-print (PDF) version of the VIS for MMR vaccine in
Arabic, go to:
http://www.immunize.org/vis/ab_mmr03.pdf
To obtain it in English, go to:
http://www.immunize.org/vis/mmr03.pdf
To obtain a ready-to-print (PDF) version of the interim VIS for
meningococcal vaccine in Thai, go to:
http://www.immunize.org/vis/th_men05.pdf
To obtain it in English, go to:
http://www.immunize.org/vis/menin05.pdf
For information about the use of VISs, and for VISs in more than 30
languages, visit IAC's VIS web section at
http://www.immunize.org/vis
AFTER THE SHOTS . . .
To obtain a ready-to-print (PDF) version of "After the shots . . . what to
do if your child has discomfort" Japanese go to:
http://www.immunize.org/catg.d/p4015-13.pdf
To obtain it in English, go to:
http://www.immunize.org/catg.d/p4015.pdf
---------------------------------------------------------------
Back to Top
(5 of 9)
September 11, 2006
NEW: CURRENT ISSUES IN IMMUNIZATION NET CONFERENCE TO FOCUS ON AVIAN
INFLUENZA
Scheduled for October 12, from noon to 1PM ET, the net conference Current
Issues in Immunization is designed to provide clinicians with up-to-date
information on immunization. The program's focus will be on avian
influenza.
This is a limited-registration event. Registration will close when the
course is full or on October 10 (midnight ET). To register, go to:
http://www2.cdc.gov/nip/isd/ciinc
The program will combine a telephone audio conference and simultaneous
online visual content. Participants can join the Q&A session by telephone
or Internet (requires Internet access and a separate phone line). For
instructions and system requirements, go to:
http://www.cdc.gov/nip/ed/ciinc/instructions.htm
For additional information, go to:
nipinfo@cdc.gov
---------------------------------------------------------------
Back to Top
(6 of 9)
September 11, 2006
NEW: FEDERAL GOVERNMENT LAUNCHES PANDEMIC INFLUENZA WEBSITE IN
SPANISH-LANGUAGE FORMAT
On August 30, the federal government Pandemic Influenza website (www.pandemicflu.gov)
launched a Spanish-language sister site. To access it, go to:
http://www.pandemicflu.gov/espanol
---------------------------------------------------------------
Back to Top
(7 of 9)
September 11, 2006
REMINDER THAT PERINATAL HEPATITIS B VIRUS (HBV) IS A NATIONALLY NOTIFIABLE
CONDITION
[The following is cross posted from IAC's Hep Express electronic
newsletter, 9/7/06.]
CDC and the Council of State and Territorial Epidemiologists would like to
remind healthcare providers that perinatal HBV infection is a nationally
notifiable condition. Perinatal HBV infection is one of more than 50
nationally notifiable conditions that are reported on a weekly basis from
state health departments to CDC through the Nationally Notifiable Diseases
Surveillance System (NNDSS). All confirmed cases of perinatal HBV
infection should be reported to CDC through the NNDSS as soon as they are
identified. The NNDSS surveillance case definition for perinatal HBV
infection is HBsAg-positivity in any infant age 1-24 months who was born
in the United States or in U.S. territories to an HBsAg-positive mother.
Reporting for perinatal HBV infection should be done by the person or
organization that identifies the HBV infection (e.g., laboratories,
physicians, perinatal hepatitis B coordinators, nurse practitioners).
These entities should collaborate with the program in each state that is
responsible for NNDSS reporting; in most states, this is the communicable
disease program. The NNDSS event code (disease code) for perinatal HBV
infection cases is 10104. If you are not currently reporting through NNDSS
or are not sure if cases are being reported, please work with your state
program to initiate reporting and to determine what data are required to
complete the case report. Guidelines for Viral Hepatitis including
perinatal HBV infection surveillance can be found at
http://www.cdc.gov/ncidod/diseases/hepatitis/resource/PDFs/revised_GUIDELINES_formatted5.pdf
---------------------------------------------------------------
Back to Top
(8 of 9)
September 11, 2006
SEPTEMBER 7 ISSUE OF HEP EXPRESS ELECTRONIC NEWSLETTER AVAILABLE ONLINE
The September 7 issue of Hep Express, an electronic newsletter published
by IAC, is now available online. It is intended for health professionals,
program planners, and advocates involved in prevention, screening, and
treatment of viral hepatitis.
IAC Express has already covered some of the information presented in the
September 7 Hep Express; titles of articles we have not yet covered
follow.
-
Coming soon: 2005 National Immunization Survey (NIS) results will be
published on September 15 in MMWR
-
Merck is experiencing temporary packaging constraints for adult
hepatitis A and B vaccines
-
Learn about best injection control practices used in the international
arena
-
LiverHope provides information, support, education, and awareness for
people with hepatitis
-
Asian Pacific American Medical Student Association (APAMSA) National
Conference coming October 6-8, 2006
-
Pacific Health Summit coming to Seattle from on June 12-14, 2007
To access the September 7 issue, go to:
http://www.hepprograms.org/hepexpress/issue47.asp
To sign up for a free subscription to Hep Express, go to:
http://www.hepprograms.org/hepexpress/signup.asp
To access previous issues of Hep Express, go to:
http://www.hepprograms.org/hepexpress
---------------------------------------------------------------
Back to Top
(9 of 9)
September 11, 2006
CDC REPORTS ON 2006 MEASLES OUTBREAK IN FIJI
CDC published "Measles Outbreak and Response—Fiji, February-May 2006" in
the September 8 issue of MMWR. Portions of a summary made available to
the press are reprinted below.
***********************
This report describes the epidemiologic finings, public health response,
and potential causes of a February-May 2006, measles outbreak that
produced 132 cases in Fiji. In September 2005, the 37 countries and
areas of the World Health Organization (WHO) Western Pacific Region (WPR)
established a goal to eliminate measles in the region by 2012. The 2006
measles outbreak in Fiji, like the 2003 Marshall Islands outbreak in
this region, underscores the importance of maintaining high population
immunity in order to prevent future outbreaks caused by importation of
measles disease.
***********************
To access a web-text (HTML) version of the complete article, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5535a3.htm
To access a ready-to-print (PDF) version of this issue of MMWR, go to:
http://www.cdc.gov/mmwr/PDF/wk/mm5535.pdf
To receive a FREE electronic subscription to MMWR (which includes new
ACIP statements), go to:
http://www.cdc.gov/mmwr/mmwrsubscribe.html |
